Health and forensic databases may contribute to racial disparities

There is too little attention paid in national and international public policy circles to the digital divide in health and law enforcement databases, says a new article in this week's PLoS Medicine.

These are the conclusions of Peter Chow-White from Simon Fraser University in Burnaby, Canada and Troy Duster from University of California, Berkeley, USA who examined the question of whether the "digital divide" in health and forensic DNA databases is contributing to .

Over the last decade, the authors say, the majority of in population studies are from individuals of European origin and individuals from Asian, African, Latino, and aboriginal groups are underrepresented. As a result, the authors argue, "forensic DNA databases are growing to mirror racial disparities in arrest practices and incarceration rates. Racial disparities in forensic DNA databases between European and African American and Latino groups is inverted from health DNA databases."

More information: Chow-White PA, Duster T (2011) Do Health and Forensic DNA Databases Increase Racial Disparities? PLoS Med 8(10): e1001100. doi:10.1371/journal.pmed.1001100

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Simulation-based training improves endoscopy execution

Oct 18, 2014

(HealthDay)—Simulation-based training (SBT) improves clinicians' performance of gastrointestinal endoscopy in both test settings and clinical practice, according to research published in the October issue ...

Data sharing in pharmaceutical industry shows progress

Oct 16, 2014

To enhance the transparency of clinical trials for new drugs, a number of pharmaceutical firms have begun sharing data with investigators outside their own companies. Brian L. Strom, chancellor of Rutgers Biomedical and Health ...

Swiss drug maker Roche posts flat 3Q sales

Oct 16, 2014

(AP)—Swiss drugmaker Roche Holding AG has reported "stable" or flat sales for the first nine months of 2013 but says the results show strong demand for its cancer drugs and emerging new products.

User comments